En poursuivant votre navigation sur ce site, vous acceptez l'utilisation d'un simple cookie d'identification. Aucune autre exploitation n'est faite de ce cookie. OK
0

Thrombopoietin-Increased DNA-PK-Dependent DNA Repair Limits Hematopoietic Stem and Progenitor Cell Mutagenesis in Response to DNA Damage

Favoris Signaler une erreur
Article
H

De Laval, B. ; Pawlikowska, P. ; Petit-Cocault, L. ; Bilhou-Nabera, C. ; Aubin-Houzelstein, Geneviève ; Souyri, M. ; Pouzoulet, F. ; Gaudry, M. ; Porteu, F.

CELL STEM CELL

1 Institut National de la Santé et de la Recherche Médicale U1016, Institut Cochin, 75014 Paris, France. 2 Centre National de la Recherche Scientifique (CNRS) UMR 8104, 75014 Paris, France. 3 Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France. 4 CNRS UMR 7622, Université Pierre et Marie Curie, 75005 Paris, France; 5 Service d'Hématologie et Immunologie Biologiques, Assistance Publique—Hôpitaux de Paris, Hôpital St. Antoine, 75012 Paris, France; 6 Institut National de la Recherche Agronomique UMR 955, Ecole Nationale Vétérinaire d'Alfort, Université Paris Est, 94704 Maisons-Alfort, France; 7 Plateforme de Radiothérapie Expérimentale, Institut Curie, 91400 Orsay, France

2012

Article

Abstract : DNA double-strand breaks (DSBs) represent a serious threat for hematopoietic stem cells (HSCs). How cytokines and environmental signals integrate the DNA damage response and contribute to HSC-intrinsic DNA repair processes remains unknown. Thrombopoietin (TPO) and its receptor, Mpl, are critical factors supporting HSC self-renewal and expansion. Here, we uncover an unknown function for TPO-Mpl in the regulation of DNA damage response. We show that DNA repair following ?-irradiation (?-IR) or the action of topoisomerase-II inhibitors is defective in Mpl?/? and in wild-type mouse or human hematopoietic stem and progenitor cells treated in the absence of TPO. TPO stimulates DNA repair in vitro and in vivo by increasing DNA-PK-dependent nonhomologous end-joining efficiency. This ensures HSC chromosomal integrity and limits their long-term injury in response to IR. This shows that niche factors can modulate the HSC DSB repair machinery and opens new avenues for administration of TPO agonists for minimizing radiotherapy-induced HSC injury and mutagenesis.
Favoris Signaler une erreur